Results 121 to 130 of about 78,156 (240)

Curved Tails in Polymerization-Based Bacterial Motility

, 2001
The curved actin ``comet-tail'' of the bacterium Listeria monocytogenes is a visually striking signature of actin polymerization-based motility. Similar actin tails are associated with Shigella flexneri, spotted-fever Rickettsiae, the Vaccinia virus, and
A. Mogilner, A.L. Rozelle, A.R. Bausch, A.V. Zvelindovsky, B. Alberts, C. Kocks, C. Kocks, C.J. Merrifield, D. Pantaloni, D.E. Koppel, E. Domann, E. Gouin, E.J. Jervis, E.L. Palmer, F. Frischknecht, F. Gerbal, F. Gerbal, F. Perrin, F.C. MacKintosh, G.A. Smith, H. Berg, I. Pagonabarraga, J. Crank, J. Steinhauer, J.A. Theriot, J.A. Theriot, J.A. Theriot, J.E. Italiano, Jr., K. Kroy, K. Luby-Phelps, L. Ma, L.A. Cameron, L.G. Tilney, L.M. Machesky, L.M. Machesky, M. A. Moors,, M. Charles, M.B. Goldberg, M.B. Goldberg, M.D. Welch, M.L. Bernardini, P.D. Frymier, R. Thar,, R.A. Brundage, R.A. Heinzen, R.A. Heinzen, S. Cudmore, S. Dramsi, S.F. Hayes, T.P. Loisel, W.L. Zeile   +50 more
core   +1 more source

Vaccination of Tamarin with Recombinant Vaccinia Virus Expressing Epstein Barr Virus (EBV) Latent Proteins

Iranian Journal of Allergy, Asthma and Immunology, 2004
The aim of this work was to see whether tamarin immunisation with recombinant vaccinia virus expressing Epstein Barr Virus latent proteins could prime T cells which were, on activation, able to inhibit the outgrowth of Epstein Barr virus transformed ...
Mahmood Mahmoodian Shooshtari, Suzan Finerty, rew John Morgan   +2 more
doaj  

Modification of H-2 Antigenic Sites by Enzymatic Treatment Influences Virus-Specific Target Cell Lysis [PDF]

, 1976
Vaccinia virus-infected cells were treated enzymatically to remove H-2 antigenic sites. The effect of this procedure on virus-specific cell-mediated cytolysis (CMC) and virus-specific antibody-mediated cytolysis (AMC) was tested. Due to the inhibition of
Ertl, H., Koszinowski, Ulrich H.
core  

Virus-Specific T-Cell Sensitization. Requirements for vaccinia virus specific T cell sensitization in vivo. [PDF]

, 1977
Ertl, Hildegund, Gerike, Rainer, Koszinowski, Ulrich H.   +2 more
core   +1 more source

Vaccinia Virus [PDF]

, 2020
openaire   +1 more source

Cell mediated cytotoxicity against Sendai virus infected cells [PDF]

, 1976
Bevan, Bhatnagar, Brunner, Gardner, Gardner, Gordon, Julius, Kedar, Kieling, Koszinowski, Koszinowski, Koszinowski, Lagrange, Lesley, Mcfarland, Pfizenmaier, Rehn, Reif, Schmitt-Verhulst, Shearer, Wagner, Zinkernagel   +21 more
core   +1 more source

Piceatannol as a potential antiviral agent against vaccinia virus at multiple stages. [PDF]

Front Microbiol
Zhang L, Liu Y, Li D, Luan J, Zhang L.
europepmc   +1 more source

Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virus. [PDF]

Mol Ther Oncol
Boulton S, Singh S, Bell JC.
europepmc   +1 more source

An oncolytic vaccinia virus encoding CD47 nanobody potentiates antitumor immunity in multiple myeloma. [PDF]

iScience
Pan L, Zhu X, Zhang J, Zhong Q, Wu H, Sun W, Xia Y, Wang S, Tong X.   +8 more
europepmc   +1 more source

IL-18-armed oncolytic vaccinia virus remodels the suppressive microenvironment via macrophage and Treg modulation in lymphoma. [PDF]

Cancer Immunol Immunother
Wu H, Zhang J, Xu L, Xie Y, Pan L, Zhang X, Xia Y, Yang F, Kang X, Tong X, Wang S.   +10 more
europepmc   +1 more source